North America Lateral Flow Assay Market Forecast to 2030
North America Lateral Flow Assay Market Forecast to 2030 – Regional Analysis – by Product Type (Kits & Reagents and Lateral Flow Readers), Technique (Sandwich Assay, Competitive Assays, and Multiplex Detection Assay), Test Type (Lateral Flow Immunoassay and Nucleic Acid Lateral Flow Assay), Application (Clinical Testing, Veterinary Diagnostics, Food Safety & Environment Testing, and Drug Development & Quality Testing), and End User (Hospitals and Clinics, Diagnostics Laboratories, Homecare, Veterinary Clinics, Pharmaceutical & Biotechnology Companies, and Others)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Use of Home-Based Assay Kits Fuels North America Lateral Flow Assay Market
Lateral flow assays (LFA) are paper-based tests designed for the detection of analytes (condition-specific biomolecules) in complex mixtures (biological samples), wherein samples are placed in a designated spot in a test device. These tests provide results within 5-30 minutes. Lateral flow assay kits exhibit stability over various environmental conditions and prolonged shelf life. Home tests based on later flow assays permit users to test self-collected samples and get results without the assistance of a trained medical professional. These tests are generally sold over the counter. A pregnancy test kit is one of the most familiar examples of home-based lateral flow assays. Further, these assays are designed for the diagnosis of infectious diseases, cardiovascular diseases, and stigmatized diseases such as HIV. Therefore, the rising prevalence of these diseases and the increasing adoption of lateral flow assay testing in home healthcare drive the lateral flow assay market growth. During the COVID-19 pandemic, many companies introduced at-home lateral flow assays for the diagnosis of SARS-CoV-2 infection due to people’s reluctance to visit hospitals or diagnostic labs for testing.
In October 2020, Siemens Healthineers launched the CLINITEST Rapid COVID-19 Antigen Self-Test that helps detect the infection in 15 minutes so that the infected individuals can be isolated sooner to avoid the disease spread.
In July 2020, BD Launched a portable, rapid point-of-care antigen test to detect SARS-CoV-2 infection in 15 minutes.
In August 2020, the US Food and Drug Administration (FDA) issued an Emergency Use Authorization for Abbott BinaxNOW COVID-19 Ag Card, a rapid test to detect the disease. BinaxNOW uses Abbott’s proven lateral flow technology, making it a friendly and reliable method for frequent mass testing among healthcare providers.
In September 2020, Roche launched a SARS-CoV-2 Rapid Antigen Test for markets accepting the CE Mark.
North America Lateral Flow Assay Market Overview
North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US held the largest North America lateral flow assay market share in 2022. The market growth in the region is characterized by the growing prevalence of various diseases, government support for advanced diagnostics adoption, and increasing efforts in R&D and other activities undertaken by market players. In addition, technological advancements in the diagnosis industry are likely to be a major driver for the North America lateral flow assay market over the coming years.
The US lateral flow assay market holds a significant share in North America. The growth of the US lateral flow assay market is attributed to the growing demand for at-home kits for pregnancy testing and the rapidly increasing incidence of infectious diseases, such as HIV, Hepatitis, H. pylori, and COVID-19. According to the Washington University School of Medicine, annually, ~20 million women in the US rely on home pregnancy tests, which boosts the adoption of lateral flow assay-based pregnancy test kits.
North America Lateral Flow Assay Market Revenue and Forecast to 2030 (US$ Million)
North America Lateral Flow Assay Market Segmentation
The North America lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.
Based on product type, the North America lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger North America lateral flow assay market share in 2022.
In terms of technique, the North America lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest North America lateral flow assay market share in 2022.
By test type, the North America lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger North America lateral flow assay market share in 2022.
Based on application, the North America lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest North America lateral flow assay market share in 2022.
By end user, the North America lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest North America lateral flow assay market share in 2022.
By country, the North America lateral flow assay market is segmented into the US, Canada, and Mexico. The US dominated the North America lateral flow assay market share in 2022.
F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America lateral flow assay market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team research, the North America lateral flow assay market was valued at US$ 3,687.12 million in 2022 and is expected to reach US$ 7,089.53 million by 2030, registering a CAGR of 8.5% from 2022 to 2030. Smartphone usage and AI integration in lateral flow immunoassay and evolving applications of lateral flow assays are among the critical factors attributed to drive the North America lateral flow assay market growth.
Smartphone-based biosensors in optical procedures involving mechanisms such as reflection, absorption, and fluorescence have been instrumental in diagnostics, medical, healthcare, food, and environmental monitoring applications. Artificial intelligence (AI) and machine learning are major technologies that drive this progress, providing real-time and highly accurate reads. With machine learning, reader software can quickly adapt to new tests launched by manufacturers.
Further, cloud-based systems may turn any tablet or smartphone into a universal digital reader, allowing healthcare organizations to perform lateral flow tests for the detection of any infection or marker on a large scale. This system allows any smartphone or tablet to become a universal digital reader, allowing healthcare organizations to roll out lateral flow testing for any disease or marker at scale. Furthermore, AI-driven innovative devices that can read a COVID-19 lateral flow diagnostic test using a user’s smartphone have received special use approval from the Medicines and Healthcare Products Regulatory Agency (MHRA). Thus, AI integration and smartphone usage are likely to trigger the demand for lateral flow assays in the healthcare sector in the coming years.
On the contrary, inconsistent assay results due to procedural limitations hamper the growth of North America lateral flow assay market.
Based on product type, the North America lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held 63.5% market share in 2022, amassing US$ 2,341.31 million. It is projected to garner US$ 4,613.43 million by 2030 to register 8.8% CAGR during 2022-2030.
In terms of technique, the North America lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held 47.5% share of North America lateral flow assay market in 2022, amassing US$ 1,750.94 million. It is anticipated to garner US$ 3,349.25 million by 2030 to expand at 8.4% CAGR during 2022-2030.
By test type, the North America lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held 66.1% share of North America lateral flow assay market in 2022, amassing US$ 2,438.94 million. It is projected to garner US$ 4,891.24 million by 2030 to expand at 9.1% CAGR from 2022 to 2030.
Based on application, the North America lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held 64.8% share of North America lateral flow assay market in 2022, amassing US$ 2,388.44 million. It is predicted to garner US$ 4,610.84 million by 2030 to expand at 8.6% CAGR between 2022 and 2030.
By end user, the North America lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held 39.7% share of North America lateral flow assay market in 2022, amassing US$ 1,464.59 million. It is estimated to garner US$ 2,902.92 million by 2030 to expand at 8.9% CAGR during 2022-2030.
Based on country, the North America lateral flow assay market is categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 83.8% share of North America lateral flow assay market in 2022. It was assessed at US$ 3,089.17 million in 2022 and is likely to hit US$ 6,108.36 million by 2030, registering a CAGR of 8.9% during 2022-2030.
Key players operating in the North America lateral flow assay market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc, among others.
In August 2023, The BD Veritor has been granted an Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) of the United States. The COVID-19 fast antigen test will interpret test results digitally using smartphone computer vision technology. There is no need for a lab, a prescription, or a protracted wait period for the test results.
In May 2022, Bio-Rad Laboratories launched the CFX Duet Real-Time PCR system to support researchers in developing singleplex and duplex quantitative PCR assays. The system offers the robust thermal performance and proprietary, accurate optical shuttle system of the company’s CFX Opus system.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America lateral flow assay market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America lateral flow assay market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Lateral Flow Assay Market – Key Industry Dynamics
4.1 North America Lateral Flow Assay Market – Key Industry Dynamics
4.2 Market Drivers
4.2.1 Increasing Use of Home-Based Assay Kits
4.2.2 Rising Popularity of Point-of-Care Testing
4.3 Market Restraints
4.3.1 Inconsistent Assay Results Due to Procedural Limitations
4.4 Market Opportunities
4.4.1 Evolving Applications of Lateral Flow Assays
4.5 Future Trends
4.5.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
4.6 Impact analysis
5. Lateral Flow Assay Market – North America Market Analysis
5.1 North America Lateral Flow Assay Market Revenue (US$ Mn), 2020 – 2030
6. North America Lateral Flow Assay Market Analysis – Product Type
6.1 Kits & Reagents
6.1.1 Overview
6.1.2 Kits & Reagents: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
6.2 Lateral Flow Readers
6.2.1 Overview
6.2.2 Lateral Flow Readers: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7. North America Lateral Flow Assay Market Analysis – Technique
7.1 Sandwich Assay
7.1.1 Overview
7.1.2 Sandwich Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7.2 Competitive Assays
7.2.1 Overview
7.2.2 Competitive Assays: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
7.3 Multiplex Detection Assay
7.3.1 Overview
7.3.2 Multiplex Detection Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
8. North America Lateral Flow Assay Market Analysis – Test Type
8.1 Lateral Flow Immunoassay
8.1.1 Overview
8.1.2 Lateral Flow Immunoassay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
8.2 Nucleic Acid Lateral Flow Assay
8.2.1 Overview
8.2.2 Nucleic Acid Lateral Flow Assay: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9. North America Lateral Flow Assay Market Analysis – Application
9.1 Clinical Testing
9.1.1 Overview
9.1.2 Clinical Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.2 Veterinary Diagnostics
9.2.1 Overview
9.2.2 Veterinary Diagnostics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.3 Food Safety & Environment Testing
9.3.1 Overview
9.3.2 Food Safety & Environment Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
9.4 Drug Development & Quality Testing
9.4.1 Overview
9.4.2 Drug Development & Quality Testing: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10. North America Lateral Flow Assay Market Analysis – End User
10.1 Hospitals and Clinics
10.1.1 Overview
10.1.2 Hospitals and Clinics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.2 Diagnostics Laboratories
10.2.1 Overview
10.2.2 Diagnostics Laboratories: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.3 Homecare
10.3.1 Overview
10.3.2 Homecare: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.4 Veterinary Clinics
10.4.1 Overview
10.4.2 Veterinary Clinics: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.5 Pharmaceutical & Biotechnology Companies
10.5.1 Overview
10.5.2 Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: North America Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
11. North America Lateral Flow Assay Market – Country Analysis
11.1 North America Lateral Flow Assay Market, Revenue and Forecast To 2030
11.1.1 North America Lateral Flow Assay Market Revenue and Forecasts and Analysis – By Country
11.1.1.1 US: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.1.1 Overview
11.1.1.1.2 US Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.1.3 US Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
11.1.1.1.4 US Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
11.1.1.1.5 US Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
11.1.1.1.6 US Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
11.1.1.1.7 US Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Canada: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.2.1 Overview
11.1.1.2.2 Canada Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.2.3 Canada Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
11.1.1.2.4 Canada Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
11.1.1.2.5 Canada Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
11.1.1.2.6 Canada Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
11.1.1.2.7 Canada Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 Mexico: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.3.1 Overview
11.1.1.3.2 Mexico Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
11.1.1.3.3 Mexico Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
11.1.1.3.4 Mexico Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
11.1.1.3.5 Mexico Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
11.1.1.3.6 Mexico Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
11.1.1.3.7 Mexico Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Lateral Flow Assay Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Becton Dickinson and Co
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 PerkinElmer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Hologic Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 QIAGEN NV
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 bioMerieux SA
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 QuidelOrtho Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Abbott Laboratories
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Merck KGaA
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Bio-Rad Laboratories Inc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
13.12 Thermo Fisher Scientific Inc
13.12.1 Key Facts
13.12.2 Business Description
13.12.3 Products and Services
13.12.4 Financial Overview
13.12.5 SWOT Analysis
13.12.6 Key Developments
14. Appendix
14.1 About the Research Team
14.2 Glossary of Terms
LIST OF TABLES
Table 2. US Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
Table 3. US Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
Table 4. US Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
Table 5. US Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 6. US Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 7. Canada Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
Table 8. Canada Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 12. Mexico Lateral Flow Assay Market, by Product Type- Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico Lateral Flow Assay Market, by Technique- Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico Lateral Flow Assay Market, by Test Type- Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico Lateral Flow Assay Market, by Application- Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico Lateral Flow Assay Market, by End User- Revenue and Forecast to 2030 (US$ Million)
Table 17. Recent Organic Growth Strategies in the Lateral Flow Assay Market
Table 18. Recent Inorganic Growth Strategies in the Lateral Flow Assay Market
Table 19. Glossary of Terms, Lateral Flow Assay Market
Â
LIST OF FIGURES
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. North America Lateral Flow Assay Market Revenue (US$ Mn), 2020 – 2030
Figure 4. North America Lateral Flow Assay Market Revenue Share, by Product Type, 2022 & 2030 (%)
Figure 5. Kits & Reagents: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 6. Lateral Flow Readers: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 7. North America Lateral Flow Assay Market Revenue Share, by Technique, 2022 & 2030 (%)
Figure 8. Process of Sandwich Lateral Flow Assay
Figure 9. Sandwich Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 10. Process of Competitive Lateral Flow Assay
Figure 11. Competitive Assays: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 12. Multiplex Detection Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 13. North America Lateral Flow Assay Market Revenue Share, by Test Type, 2022 & 2030 (%)
Figure 14. Lateral Flow Immunoassay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 15. Nucleic Acid Lateral Flow Assay: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 16. North America Lateral Flow Assay Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 17. Clinical Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 18. Veterinary Diagnostics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 19. Food Safety & Environment Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 20. Drug Development & Quality Testing: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 21. North America Lateral Flow Assay Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Hospitals and Clinics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 23. Diagnostics Laboratories: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 24. Homecare: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 25. Veterinary Clinics: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 26. Pharmaceutical & Biotechnology Companies: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 27. Others: North America Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Million)
Figure 28. North America Lateral Flow Assay Market, by Key Country – Revenue (2022) (US$ Million)
Figure 29. North America Lateral Flow Assay Market Breakdown by Key Countries, 2022 and 2030 (%)
Figure 30. US Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 31. Canada Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 32. Mexico Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
Figure 33. Growth Strategies in the Lateral Flow Assay Market
1. Abbott Laboratories
2. Becton Dickinson and Co
3. bioMerieux SA
4. Bio-Rad Laboratories Inc
5. F. Hoffmann-La Roche Ltd
6. Hologic Inc
7. Merck KGaA
8. PerkinElmer Inc
9. QIAGEN NV
10. QuidelOrtho Corp
11. Siemens Healthineers AG
12. Thermo Fisher Scientific Inc
You must be logged in to post a review.
Reviews
There are no reviews yet.